Search all medical codes

Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional

CPT4 code

Name of the Procedure:

Interrogation Device Evaluation(s) (Remote), Up to 90 Days; Single, Dual, or Multiple Lead Pacemaker System, or Leadless Pacemaker System with Interim Analysis, Review(s) and Report(s) by a Physician or Other Qualified Health Care Professional

Summary

Interrogation device evaluation is a diagnostic procedure that remotely monitors and assesses the functioning of a pacemaker system over a period of up to 90 days. This allows healthcare professionals to analyze the device's performance and make any necessary adjustments to ensure it is operating properly.

Purpose

This procedure addresses the need to regularly monitor pacemaker systems to ensure they are functioning correctly and effectively. The goal is to detect and correct any issues with the pacemaker, optimizing its performance and ensuring the patient's heart maintains proper rhythm.

Indications

  • Patients with existing pacemaker systems (single, dual, multiple lead, or leadless).
  • Individuals experiencing symptoms such as dizziness, fatigue, chest pain, or shortness of breath that suggest possible pacemaker malfunction.
  • Regular follow-up after pacemaker implantation to ensure proper function and longevity of the device.

Preparation

  • Patients may need to continue their normal medications unless otherwise directed.
  • No specific fasting or special preparation is typically required.
  • Routine diagnostic assessments, such as an ECG (electrocardiogram), may be performed before the evaluation starts.

Procedure Description

  1. The patient is provided with a remote monitoring device that communicates with their pacemaker system.
  2. Over the next 90 days, the device records data about the pacemaker's performance, including battery status, electrical activity, and any irregularities in heart rhythm.
  3. Healthcare professionals intermittently review the collected data.
  4. Interim analyses are conducted to ensure the pacemaker is functioning properly and make any necessary adjustments.
  5. A final report is prepared by a physician or qualified health care professional summarizing the findings and any actions taken.

Duration

The monitoring period lasts up to 90 days, but the actual setup and initial instructions usually take about 30 minutes. Each interim analysis and review typically takes 15-30 minutes.

Setting

This procedure is primarily conducted remotely with data being reviewed by healthcare professionals in a clinical setting, such as a hospital or outpatient clinic.

Personnel

  • Cardiologists or electrophysiologists specializing in pacemaker management.
  • Technicians or nurses trained in remote device monitoring and data collection.
  • A physician or other qualified healthcare professional responsible for the final review and analysis.

Risks and Complications

  • Rare risk of data transmission issues which might delay monitoring.
  • Minimal risk of incorrect adjustments if data is not interpreted accurately.
  • No physical risk to the patient as it is a non-invasive procedure.

Benefits

  • Continuous and comprehensive assessment of pacemaker function.
  • Prompt detection and correction of issues, preventing possible complications.
  • Increased peace of mind for patients knowing their device is being closely monitored.

Recovery

  • No recovery time is needed since this is a non-invasive, remote monitoring procedure.
  • Patients can continue their daily activities without interruption.
  • Follow-up appointments may be scheduled if issues are detected and require in-person intervention.

Alternatives

  • In-person pacemaker check-ups, though less convenient and frequent.
  • Manual adjustments and checks using traditional external devices.
  • Pros of the remote approach include convenience and continuous monitoring; cons might include reliance on technology and potential transmission issues.

Patient Experience

  • Patients usually feel no difference during the monitoring period.
  • Minimal to no discomfort, as no physical interaction with the pacemaker is needed.
  • Regular updates can provide reassurance and reduce anxiety related to the function of their pacemaker.

Medical Policies and Guidelines for Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional

Related policies from health plans

Similar Codes